We are live on
!
Find out more
OHCM
Orchard Hill Capital Management Portfolio holdings
AUM
$22.6M
1-Year Est. Return
3.52%
This Fund
S&P 500
This Quarter
Est. Return
-0.16%
1 Year Est. Return
-3.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.32B
AUM Growth
-$280M
(-18%)
Cap. Flow
-$1.59B
Cap. Flow
% of AUM
-120.23%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
1
Closed
3
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Opko Health
OPK
|
+$64.8M |
| 2 |
Supernus Pharmaceuticals
SUPN
|
+$1.13M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 0.75% |
| 2 | Consumer Discretionary | 0.03% |
Similar funds
AC
WA
ACM
ADICC
SC
3NC
IT
BR
Orchard Hill Capital Management's Q3 2014 Portfolio in Review
As of Q3 2014, Orchard Hill Capital Management held 9 positions worth $1.32B, down 18% from $1.6B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Orchard Hill Capital Management withdrew a net $1.59B in Q3 2014, closing 3 positions and reducing 1 holding. Its most notable exit was Opko Health, an estimated $64.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 0.75% of assets, down from 4.9% a quarter earlier, followed by Consumer Discretionary.
- Orchard Hill Capital Management's biggest Q3 2014 reduction was Supernus Pharmaceuticals, cutting an estimated $1.13M.
- Orchard Hill Capital Management fully exited Opko Health in Q3 2014, selling an estimated $64.8M.
- Orchard Hill Capital Management's ten largest holdings make up 100% of its $1.32B portfolio in Q3 2014.
- Orchard Hill Capital Management opened 0 new positions and closed 3 in Q3 2014.
- Orchard Hill Capital Management's portfolio value fell 18% quarter-over-quarter to $1.32B.
Based on Orchard Hill Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.